Takeda Pharmaceutical Company Limited (NYSE:TAK) Shares Sold by Yousif Capital Management LLC

Yousif Capital Management LLC reduced its holdings in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK) by 1.6% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 48,119 shares of the company’s stock after selling 792 shares during the period. Yousif Capital Management LLC’s holdings in Takeda Pharmaceutical were worth $637,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds also recently added to or reduced their stakes in the company. FMR LLC increased its holdings in shares of Takeda Pharmaceutical by 10.9% in the third quarter. FMR LLC now owns 2,908,918 shares of the company’s stock valued at $41,365,000 after purchasing an additional 286,052 shares during the period. Stifel Financial Corp increased its holdings in shares of Takeda Pharmaceutical by 103.9% in the third quarter. Stifel Financial Corp now owns 440,666 shares of the company’s stock valued at $6,266,000 after purchasing an additional 224,594 shares during the period. Summit Global Investments increased its holdings in shares of Takeda Pharmaceutical by 86.0% in the third quarter. Summit Global Investments now owns 415,558 shares of the company’s stock valued at $5,909,000 after purchasing an additional 192,143 shares during the period. Crossmark Global Holdings Inc. increased its holdings in shares of Takeda Pharmaceutical by 284.9% in the fourth quarter. Crossmark Global Holdings Inc. now owns 210,484 shares of the company’s stock valued at $2,787,000 after purchasing an additional 155,795 shares during the period. Finally, Van ECK Associates Corp increased its holdings in shares of Takeda Pharmaceutical by 6.6% in the third quarter. Van ECK Associates Corp now owns 2,175,236 shares of the company’s stock valued at $30,149,000 after purchasing an additional 134,407 shares during the period. 9.17% of the stock is owned by institutional investors and hedge funds.

Takeda Pharmaceutical Stock Down 0.6 %

Shares of TAK stock opened at $13.54 on Monday. The stock’s 50-day simple moving average is $13.26 and its 200-day simple moving average is $13.88. The company has a debt-to-equity ratio of 0.63, a quick ratio of 0.72 and a current ratio of 1.31. The firm has a market capitalization of $43.07 billion, a PE ratio of 33.84, a P/E/G ratio of 0.24 and a beta of 0.51. Takeda Pharmaceutical Company Limited has a fifty-two week low of $12.57 and a fifty-two week high of $15.08.

Takeda Pharmaceutical (NYSE:TAK) last announced its quarterly earnings data on Thursday, January 30th. The company reported $0.42 earnings per share for the quarter, beating analysts’ consensus estimates of $0.34 by $0.08. Takeda Pharmaceutical had a return on equity of 9.39% and a net margin of 4.53%. Equities analysts expect that Takeda Pharmaceutical Company Limited will post 1.64 earnings per share for the current year.

Takeda Pharmaceutical Company Profile

Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived therapies, immunology, oncology, and neuroscience.